CSIMarket Company Name, Ticker, Customers, else..
 
Exact Sciences Corporation  (EXAS)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Exact Sciences Income Statement Quarterly

EXAS


Select the Financial Report:   Period:   Fiscal Year:

New: More EXAS's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 699.26 637.52 628.34 622.09
Revenue From Contract With Customer Including Assessed Tax - - - -
Investment Income Expense Nonoperating 11.80 6.21 2.07 4.83
Other Revenue - - - 0.00
Total Revenue 711.07 643.74 672.22 630.40 626.92
Cost of Revenue 189.85 170.10 171.87 168.53 156.99
Gross Profit 521.22 473.64 500.35 461.88 469.93
Selling, Administration, Marketing 185.27 192.37 190.48 173.16 176.49
Depriciation & Amortization 23.31 23.31 23.31 22.99 22.93
Research and Development Expense 120.88 110.61 114.92 111.45 104.10
Impairment of Long-Lived Assets Held-for-use 8.15 4.45 - - 0.55
Other operatinig exp. /-income 209.86 249.60 239.48 147.43 242.79
Unusual Expense /-Income - - - - -
Total operating costs including COS 737.32 750.43 740.06 623.55 703.85
Operating income/-loss -26.26 -106.69 -67.84 6.85 -76.93
Other Deductions / - Income
Interest expense 0.11 7.94 0.35 7.87 7.82
Interest income - - - - -
Net interest expense/-income 0.11 7.94 0.35 7.87 7.82
Investment Income, Interest - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -12.02 -6.21 -17.81 -2.07 -4.83
Total costs & expenses 725.41 752.16 722.59 629.36 706.84
Income /-loss before income taxes -14.35 -108.42 -50.38 1.04 -79.92
Income taxes expenses/-benefit 1.46 1.81 -0.61 0.25 1.11
Income after income taxes -15.81 -110.23 -49.77 0.79 -81.03
Net income/-loss of other equity - - - 0.00 -
Income/-loss from cont. Ops. -15.81 -110.23 -49.77 0.79 -81.03
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -15.81 -110.23 -49.77 0.79 -81.03
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -15.81 -110.23 -49.77 0.79 -81.03
EBIT -14.23 -100.48 -50.03 8.91 -72.10
EBITD 15.45 -69.85 -50.03 38.18 -44.59
EBITDA 38.76 -46.54 -26.72 61.17 -21.66


Per Share (GAAP Quarterly, in $) (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Basic EPS (excl. extra items) -0.09 -0.60 -0.27 0.00 -0.45
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.09 -0.60 -0.27 0.00 -0.45
Basic shares outstanding (Mill. of Units) 184.31 182.35 181.15 180.65 180.20
   EPS other shares - - - - -
Diluted Net EPS -0.09 -0.60 -0.27 0.00 -0.45
Diluted average shares (Mill. of Units) 184.31 182.35 180.66 184.08 180.20
Dividend per share - - - - -



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com